Reshaping the HIV treatment and prevention landscape
R&D approach focused on the science of the immune system, human genetics
and advanced technologies
R&D approach
-
-
-
Focus on the science of the immune system given its
importance in the pathophysiology of many diseases
Focus on human genetics, functional genomics and
advanced technologies to enable identification of novel
targets with higher POS
Strategic and disciplined BD
Improved life cycle innovation
Improved pipeline and productivity
-
-
-
-
20 vaccines, 42 medicines, the majority FiC/BIC
11 new approvals since 2017
Doubled the number of assets in pivotal studies
Significantly reduced development cycle times
Clear synergies across Vaccines and Pharma
-
Best-in-class talent
POS probability of success; BD business development; FiC First-in-Class; BiC Best-in-Class.
-
Focus on the science of the immune system
-
to both treat and prevent disease
Leadership in infectious diseases
- One capital allocation approach
-
-
One Development organisation
Broadest suite of platform technologies
gsk
44View entire presentation